Tradestie Institutional Equity Comparison Engine
ELVN vs DNTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ELVN Overall Edge
ELVN Captures Institutional Edge (2โ0 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enliven Therapeutics, Inc. Common Stock (ELVN) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, ELVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DNTH at N/M Forward P/E and -8683.9% operating margin (+205.6% YoY). In options structure, ELVN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against DNTH sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ELVN N/M vs DNTH N/M Fwd P/E
Growth & Margin Winner
ELVN
Op Margin 0.0% vs -8683.9% ยท YoY +0.0% vs +205.6%
Momentum & Technical Winner
ELVN
1Y +134.5% vs +149.5% ยท 52W Pos 69% vs 65%
Options & Structure Winner
Tie
CONSOLIDATION (5th %ile IV) vs CONSOLIDATION (7th %ile IV)
ELVN
NASDAQ
Enliven Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$47.54
-2.58% 1D
Market Cap
$3.6B
1M Return
+27.38%
1Y Return
+134.53%
Forward P/E
N/M
Unified AI Score
35.9 / 100
SELL
Tech 15.0
Fund 42.0
Flow 68.0
Mom 60.0
DNTH
NASDAQ
Dianthus Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$88.58
-3.52% 1D
Market Cap
$5.2B
1M Return
+22.87%
1Y Return
+149.51%
Forward P/E
N/M
Unified AI Score
34.1 / 100
SELL
Tech 8.0
Fund 43.0
Flow 68.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ELVN +134.53%
DNTH +149.51%
Spread: +14.98 pp (DNTH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ELVN TTM Op. Margin: 0.0%
DNTH TTM Op. Margin: -8683.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELVN vs DNTH. Trailing 12-month operating profitability (ELVN 0.0% vs DNTH -8683.9%) and valuation multiples (ELVN N/M vs DNTH N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ELVN | DNTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.6B | $5.2B | Larger Scale | DNTH |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +205.6% | Higher Growth | DNTH |
| Operating Margin (TTM) Profitability | 0.0% | -8683.9% | Higher Margin | ELVN |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -16.8% | -22.6% | Higher ROE | ELVN |
| 52-Week Range Position Momentum | 69% ($15โ$62) | 65% ($34โ$118) | Stronger Trend | ELVN |
| Beta / 30D Volatility Risk Regime | 0.96ฮฒ ยท 60% Vol | 1.03ฮฒ ยท 41% Vol | Lower Realized Risk | DNTH |
| Unified Institutional Score Composite Signal | 35.9 / 100 (SELL) | 34.1 / 100 (SELL) | Higher Composite | ELVN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ELVN vs DNTH Buy Guide
ELVN
CONSOLIDATION
59d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
DNTH
CONSOLIDATION
149d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ELVN nor DNTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.